Search results
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 2 days agoWith its OpenAI partnership, Moderna hopes to implement AI across its business, with a goal to bring...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 2 days agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 3 days agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Arbutus Biopharma Corp (ABUS) Q1 2024 Earnings Call Transcript H
Guru Focus· 3 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. Arbutus Biopharma Corp (ABUS, Financial) has initiated patient screening in their third Phase ...
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Digital Journal· 3 days agoReports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula; reaffirms 2024 ...
Two possible bird flu vaccines could be available within weeks, if needed
NBC News via Yahoo News· 3 days agoThe U.S. has two vaccines ready that could begin shipping widely within a few weeks if the H5N1 bird...